Literature DB >> 31838328

Design, synthesis and discovery of andrographolide derivatives against Zika virus infection.

Feng Li1, Emily M Lee2, Xia Sun1, Decai Wang1, Hengli Tang3, Guo-Chun Zhou4.   

Abstract

The Zika endemic established by imported and local transmission is of significant concern and effective anti-ZIKV drugs remain an urgent unmet need. As andrographolide was identified to be an inhibitor of DENV and CHIKV and the importance of quinoline structure against infectious diseases was considered, we are interested in studying its andrographolide derivatives with quinoline moiety against Zika virus infection. In addition to screening eight in-house derivatives of andrographolide, sixteen new derivatives were designed, synthesized and tested against Zika virus infection. Among these compounds, two most potent anti-Zika compounds of 19-acetylated 14α-(5',7'-dichloro-8'-quinolyloxy) derivative 17b and 14β-(8'-quinolyloxy)-3,19- diol derivative 3 with the highest selectivity were discovered. The SAR analysis indicates that rational and optimal combined modification/s at 3-, 14-, or 19-positions can make derivatives less toxic and more potent against Zika infection, and both of 3 and 17b are suitable as leads for designing new generation of andrographolide derivatives with quinoline or its structure- and property-related moieties against Zika virus and other arboviruses.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  14α-(8′-quinolyloxy); Andrographolide and derivative; Antiviral; Quinolyloxy; Zika virus

Mesh:

Substances:

Year:  2019        PMID: 31838328      PMCID: PMC6980694          DOI: 10.1016/j.ejmech.2019.111925

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  54 in total

1.  Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity.

Authors:  Susana V Bardina; Paul Bunduc; Shashank Tripathi; James Duehr; Justin J Frere; Julia A Brown; Raffael Nachbagauer; Gregory A Foster; David Krysztof; Domenico Tortorella; Susan L Stramer; Adolfo García-Sastre; Florian Krammer; Jean K Lim
Journal:  Science       Date:  2017-03-30       Impact factor: 47.728

2.  A phase I trial of andrographolide in HIV positive patients and normal volunteers.

Authors:  C Calabrese; S H Berman; J G Babish; X Ma; L Shinto; M Dorr; K Wells; C A Wenner; L J Standish
Journal:  Phytother Res       Date:  2000-08       Impact factor: 5.878

Review 3.  Current status of therapeutic and vaccine approaches against Zika virus.

Authors:  Braira Wahid; Amjad Ali; Shazia Rafique; Muhammad Idrees
Journal:  Eur J Intern Med       Date:  2017-08-07       Impact factor: 4.487

4.  Dehydroandrographolide succinic acid monoester as an inhibitor against the human immunodeficiency virus.

Authors:  R S Chang; L Ding; G Q Chen; Q C Pan; Z L Zhao; K M Smith
Journal:  Proc Soc Exp Biol Med       Date:  1991-05

5.  Zika viral dynamics and shedding in rhesus and cynomolgus macaques.

Authors:  Christa E Osuna; So-Yon Lim; Claire Deleage; Bryan D Griffin; Derek Stein; Lukas T Schroeder; Robert Were Omange; Katharine Best; Ma Luo; Peter T Hraber; Hanne Andersen-Elyard; Erwing Fabian Cardozo Ojeda; Scott Huang; Dana L Vanlandingham; Stephen Higgs; Alan S Perelson; Jacob D Estes; David Safronetz; Mark G Lewis; James B Whitney
Journal:  Nat Med       Date:  2016-10-03       Impact factor: 53.440

Review 6.  Multi-targeting Andrographolide and its Natural Analogs as Potential Therapeutic Agents.

Authors:  V Kishore; Nagendra Sastry Yarla; Anupam Bishayee; Swathi Putta; Ramarao Malla; Nageswara Rao Reddy Neelapu; Surekha Challa; Subhasish Das; Yallappa Shiralgi; Gurumurthy Hegde; Bhadrapura Lakkappa Dhananjaya
Journal:  Curr Top Med Chem       Date:  2017       Impact factor: 3.295

7.  Activity of andrographolide and its derivatives against influenza virus in vivo and in vitro.

Authors:  Jian-Xin Chen; Hui-Jun Xue; Wen-Cai Ye; Bing-Hu Fang; Ya-Hong Liu; Shao-Hua Yuan; Pei Yu; Yu-Qiang Wang
Journal:  Biol Pharm Bull       Date:  2009-08       Impact factor: 2.233

Review 8.  Andrographolide and analogues in cancer prevention.

Authors:  Siddhartha Kumar Mishra; Swati Tripathi; Archana Shukla; Seung Hyun Oh; Hwan Mook Kim
Journal:  Front Biosci (Elite Ed)       Date:  2015-01-01

9.  Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models.

Authors:  Rodrigo Delvecchio; Luiza M Higa; Paula Pezzuto; Ana Luiza Valadão; Patrícia P Garcez; Fábio L Monteiro; Erick C Loiola; André A Dias; Fábio J M Silva; Matthew T Aliota; Elizabeth A Caine; Jorge E Osorio; Maria Bellio; David H O'Connor; Stevens Rehen; Renato Santana de Aguiar; Andrea Savarino; Loraine Campanati; Amilcar Tanuri
Journal:  Viruses       Date:  2016-11-29       Impact factor: 5.048

10.  Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease.

Authors:  Ankur Kumar; Brooke Liang; Murali Aarthy; Sanjeev Kumar Singh; Neha Garg; Indira U Mysorekar; Rajanish Giri
Journal:  ACS Omega       Date:  2018-12-24
View more
  9 in total

Review 1.  Evidence Supporting a Phased Immuno-physiological Approach to COVID-19 From Prevention Through Recovery.

Authors:  S F Yanuck; J Pizzorno; H Messier; K N Fitzgerald
Journal:  Integr Med (Encinitas)       Date:  2020

2.  Discovery and synthesis of 1,2,4-oxadiazole derivatives as novel inhibitors of Zika, dengue, Japanese encephalitis, and classical swine fever virus infections.

Authors:  Sangwoo Nam; Hyo Gyeong Na; Eun Hye Oh; Eunhye Jung; Yeon Hee Lee; Eun Ju Jeong; Yu-Da Ou; Bin Zhou; Sunjoo Ahn; Jin Soo Shin; Soo Bong Han; Yun Young Go
Journal:  Arch Pharm Res       Date:  2022-04-20       Impact factor: 4.946

3.  Andrographolide Suppresses Pyroptosis in Mycobacterium tuberculosis-Infected Macrophages via the microRNA-155/Nrf2 Axis.

Authors:  Yan Fu; Jingjing Shen; Fanglin Liu; Hemin Zhang; Yuejuan Zheng; Xin Jiang
Journal:  Oxid Med Cell Longev       Date:  2022-04-28       Impact factor: 7.310

Review 4.  Andrographolide: A Herbal-Chemosynthetic Approach for Enhancing Immunity, Combating Viral Infections, and Its Implication on Human Health.

Authors:  Archana Mishra; Haq Abdul Shaik; Rakesh Kumar Sinha; Bakht Ramin Shah
Journal:  Molecules       Date:  2021-11-21       Impact factor: 4.411

5.  Discovery of Novel Andrographolide Derivatives as Antiviral Inhibitors against Human Enterovirus A71.

Authors:  Jie Kai Tan; Ran Chen; Regina Ching Hua Lee; Feng Li; Kun Dai; Guo-Chun Zhou; Justin Jang Hann Chu
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-18

6.  Andrographolide and Deoxyandrographolide Inhibit Protease and IFN-Antagonist Activities of Foot-and-Mouth Disease Virus 3Cpro.

Authors:  Sirin Theerawatanasirikul; Varanya Lueangaramkul; Nattarat Thangthamniyom; Penpitcha Chankeeree; Ploypailin Semkum; Porntippa Lekcharoensuk
Journal:  Animals (Basel)       Date:  2022-08-07       Impact factor: 3.231

Review 7.  Quinoline derivatives volunteering against antimicrobial resistance: rational approaches, design strategies, structure activity relationship and mechanistic insights.

Authors:  Nitish Kumar; Aanchal Khanna; Komalpreet Kaur; Harmandeep Kaur; Anchal Sharma; Preet Mohinder Singh Bedi
Journal:  Mol Divers       Date:  2022-10-05       Impact factor: 3.364

8.  Molecular Cloning and Differential Gene Expression Analysis of 1-Deoxy-D-xylulose 5-Phosphate Synthase (DXS) in Andrographis paniculata (Burm. f) Nees.

Authors:  Mote Srinath; Aayeti Shailaja; Byreddi Bhavani Venkata Bindu; Charu Chandra Giri
Journal:  Mol Biotechnol       Date:  2020-11-22       Impact factor: 2.695

9.  Synthesis and Characterization of Andrographolide Derivatives as Regulators of βAPP Processing in Human Cells.

Authors:  Arpita Dey; Ran Chen; Feng Li; Subhamita Maitra; Jean-Francois Hernandez; Guo-Chun Zhou; Bruno Vincent
Journal:  Molecules       Date:  2021-12-17       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.